Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.
暂无分享，去创建一个
G. Hortobagyi | V. Valero | D. Booser | R. Theriault | A. Buzdar | D. Podoloff | R. Walters | N. Azarnia | M. Ewer | L. Lee | J. Willey | B. Mackay | G. A. Fonseca